Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteosageuniversitypa...
Blogosagepartners.com...
Twitter@OsageVC
Phone484-434-2255
Emailinfo@osagepartner...
Employees
Founded1/2009

Funds

Venture capital fund, 2/2011 $100M

Offices

HQ
50 Monument Road
Suite 201
Bala Cynwyd, PA, 19004
USA

People

Managing Partner
Managing Partner
Managing Partner
Founding Partner
Vice President
Senior Associate
Associate
Associate
Controller

Tags

Osage University Partners

Osage University Partners (“OUP”) is a new venture capital fund that invests in university start-ups. OUP partners with high quality universities to serve as their coinvestment vehicle in start-ups that are licensing their technology.

Recent Milestones

Investments

Company Date Round Size Participants
Kolltan Pharmaceuticals 3/2014Series D$60M5
Infinio 12/2013Series B$12M4
Immune Design 10/2013Series C$49M6
Sideris Pharmaceuticals 10/2013Series A$32M3
Otonomy 9/2013Series C$45.9M8
Evolv Technologies 8/2013Venture Round$11.8M4
Kymeta 6/2013Series C$50M5
Effector Therapeutics 5/2013Venture Round$45M7
Skytree 4/2013Series A$18M5
MC10 12/2012Series C$10M7
Urjanet 12/2012Series B$2M2
Applied Genetics Technologies Corporation 11/2012Series B$37.5M6
Cardioxyl Pharmaceuticals 11/2012Series B$28M4
Clinipace WorldWide 10/2012Series C$9M1
Mirna Therapeutics 10/2012Series C$34.5M5
Atterocor 8/2012Series A$16M3
SolarBridge Technologies 5/2012Series D$25M3
Receptos 3/2012Venture Round$30M6
Liquid Light 12/2011Series A$8.5M5
Sera Prognostics 11/2011Series A$19.3M5
Tangent Medical Technologies 11/2011Series A$4.5M2
Cleave Biosciences 10/2011Series A$44M6
Clinipace WorldWide 9/2011Series C$15M4
MC10 6/2011Series B$12.5M4
SolarBridge Technologies 6/2011Series C$19M4
Aerie Pharmaceuticals 3/2011Series B$41.4M5
Immune Design 7/2010Series B$32M5
MC10 7/2010Series A$6.21M4
CampaignerCRM 1/2010Venture Round$8M3
Luxtera 12/2009Series B$10M7
Virdante Pharmaceuticals 11/2009Series A$30M6
Corridor Pharmaceuticals 10/2009Series A$10.8M4
Gevo 8/2009Venture Round$40M7
Avid Radiopharmaceuticals 5/2009Series D$34.5M8
Kolltan Pharmaceuticals 7/2008Series A$40M5

Videos

Sources

  1. Osage closes lid on $100M war chest for university start-ups (blogoup.com) [edit]
  2. Wall Street Journal (online.wsj.com) [edit]
  3. Kolltan Pharmaceuticals Completes $60M Series D Financing (finsmes.com) [edit]
  4. Infinio Systems Closes $12M Series B Financing (finsmes.com) [edit]
  5. Immune Design Closes an up to $49M Series C Financing (finsmes.com) [edit]
  6. Sideris Pharmaceuticals completes $32m equity financing (boston.com) [edit]
  7. Otonomy completes $45.9m Series C financing (finsmes.com) [edit]
  8. Evolv Technologies Raises $11.8M in Funding (finsmes.com) [edit]
  9. Kymeta Closes $50M Series C Financing (finsmes.com) [edit]
  10. Effector Therapeutics snags $45M venture round from A-list backers (fiercebiotech.com) [edit]
  11. Skytree Secures $18 Million in Funding to Fuel Explosive Growth in the Big Data Analytics Market (skytree.net) [edit]
  12. New Strategic Investors Team Up with MC10 to Revolutionize Healthcare (mc10inc.com) [edit]
  13. SEC (sec.gov) [edit]
  14. Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding (biospace.com) [edit]
  15. Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing Led by OrbiMed Advisors (cardioxyl.com) [edit]
  16. Clinipace Announces $9 Million Series C2 Funding (clinipace.com) [edit]
  17. Mirna Therapeutics Completes $34.5M Series C Financing (finsmes.com) [edit]
  18. Atterocor Raises $16M in Series A Funding (finsmes.com) [edit]
  19. SolarBridge Technologies Raises $25M in Series D Funding (finsmes.com) [edit]
  20. Osage University Partners Source [edit]
  21. Osage University Partners [edit]
  22. Sera Secures $19.3 million Financing; Appoints Greg C. Critchfield, MD as Chief Executive Officer (seraprognostics.com) [edit]
  23. Tangent Medical Closes $4.5 Million Series A Financing (businesswire.com) [edit]
  24. Cleave Biosciences Raises $42M in Series A Financing (finsmes.com) [edit]
  25. Clinipace Worldwide Closes $15M Series C Funding Round (finsmes.com) [edit]
  26. MC10 taps Braemar to lead new $12.5M Series B round (masshightech.com) [edit]
  27. SolarBridge Technologies Secures $19m in Series C Funding (finsmes.com) [edit]
  28. SEC (sec.gov) [edit]
  29. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]
  30. SEC D (sec.gov) [edit]
  31. Landslide raises $8M, appoints former Mzinga CEO Faulk (masshightech.com) [edit]
  32. Osage University Partners Source [edit]
  33. Virdante Pharmaceuticals, Inc.: Series A $30M (onbiovc.com) [edit]
  34. Corridor Pharmaceuticals-Receives-$10,750,000 (venturedeal.com) [edit]
  35. Osage University Partners Source [edit]
  36. Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing (avidrp.com) [edit]
  37. Osage University Partners [edit]
Edit This Page
Last Edited 3/26/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy